A detailed history of Engineers Gate Manager LP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 30,670 shares of GILD stock, worth $2.88 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
30,670
Previous 137,892 77.76%
Holding current value
$2.88 Million
Previous $9.46 Million 72.83%
% of portfolio
0.05%
Previous 0.22%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$66.59 - $83.99 $7.14 Million - $9.01 Million
-107,222 Reduced 77.76%
30,670 $2.57 Million
Q2 2024

Aug 14, 2024

BUY
$63.15 - $72.88 $5.97 Million - $6.89 Million
94,521 Added 217.94%
137,892 $9.46 Million
Q1 2024

May 15, 2024

SELL
$71.58 - $87.29 $280,164 - $341,653
-3,914 Reduced 8.28%
43,371 $3.18 Million
Q4 2023

Feb 14, 2024

BUY
$73.27 - $83.09 $2.08 Million - $2.36 Million
28,409 Added 150.5%
47,285 $3.83 Million
Q3 2023

Nov 14, 2023

SELL
$73.94 - $80.67 $2.96 Million - $3.23 Million
-40,069 Reduced 67.98%
18,876 $1.41 Million
Q2 2023

Aug 14, 2023

BUY
$76.01 - $86.7 $3.96 Million - $4.52 Million
52,146 Added 766.97%
58,945 $4.54 Million
Q1 2023

May 15, 2023

BUY
$77.31 - $88.08 $181,523 - $206,811
2,348 Added 52.75%
6,799 $564,000
Q4 2022

Feb 14, 2023

SELL
$62.32 - $89.47 $851,478 - $1.22 Million
-13,663 Reduced 75.43%
4,451 $382,000
Q3 2022

Nov 14, 2022

SELL
$59.54 - $68.01 $781,879 - $893,107
-13,132 Reduced 42.03%
18,114 $1.12 Million
Q2 2022

Aug 15, 2022

SELL
$57.72 - $65.01 $173,968 - $195,940
-3,014 Reduced 8.8%
31,246 $1.93 Million
Q1 2022

May 16, 2022

BUY
$57.92 - $72.58 $1.11 Million - $1.4 Million
19,231 Added 127.96%
34,260 $2.04 Million
Q4 2021

Feb 14, 2022

BUY
$64.88 - $73.64 $532,599 - $604,510
8,209 Added 120.37%
15,029 $1.09 Million
Q3 2021

Nov 15, 2021

BUY
$67.69 - $73.03 $461,645 - $498,064
6,820 New
6,820 $476,000
Q2 2021

Aug 16, 2021

SELL
$63.47 - $69.35 $312,589 - $341,548
-4,925 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$60.0 - $68.46 $1.95 Million - $2.23 Million
-32,535 Reduced 86.85%
4,925 $318,000
Q4 2020

Feb 16, 2021

BUY
$56.65 - $64.55 $792,476 - $902,989
13,989 Added 59.6%
37,460 $2.18 Million
Q3 2020

Nov 16, 2020

BUY
$62.1 - $78.08 $1.27 Million - $1.59 Million
20,391 Added 662.05%
23,471 $1.48 Million
Q2 2020

Aug 17, 2020

SELL
$72.34 - $84.0 $1.61 Million - $1.86 Million
-22,201 Reduced 87.82%
3,080 $237,000
Q1 2020

May 15, 2020

SELL
$62.63 - $80.22 $3.36 Million - $4.3 Million
-53,574 Reduced 67.94%
25,281 $1.89 Million
Q4 2019

Feb 14, 2020

SELL
$61.62 - $67.78 $2.54 Million - $2.8 Million
-41,256 Reduced 34.35%
78,855 $5.12 Million
Q3 2019

Nov 14, 2019

BUY
$62.51 - $69.0 $1.56 Million - $1.72 Million
24,934 Added 26.2%
120,111 $7.61 Million
Q2 2019

Aug 14, 2019

BUY
$61.87 - $69.38 $5.89 Million - $6.6 Million
95,177 New
95,177 $6.43 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.